92 related articles for article (PubMed ID: 24464005)
41. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
[TBL] [Abstract][Full Text] [Related]
42. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
[TBL] [Abstract][Full Text] [Related]
43. Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.
Bonneterre J; Roché H; Kerbrat P; Fumoleau P; Goudier MJ; Fargeot P; Montcuquet P; Clavère P; Barats JC; Monnier A; Veyret C; Datchary J; Van Praagh I; Chapelle-Marcillac I
J Clin Oncol; 2004 Aug; 22(15):3070-9. PubMed ID: 15284257
[TBL] [Abstract][Full Text] [Related]
44. Oral UFT and cyclophosphamide combination chemotherapy for metastatic breast cancer.
Ogawa Y; Ishikawa T; Chung SH; Ikeda K; Takashima T; Onoda N; Nakata B; Nishiguchi Y; Hirakawa K
Anticancer Res; 2003; 23(4):3453-7. PubMed ID: 12926089
[TBL] [Abstract][Full Text] [Related]
45. First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
Viens P; Palangié T; Janvier M; Fabbro M; Roché H; Delozier T; Labat JP; Linassier C; Audhuy B; Feuilhade F; Costa B; Delva R; Cure H; Rousseau F; Guillot A; Mousseau M; Ferrero JM; Bardou VJ; Jacquemier J; Pouillart P
Br J Cancer; 1999 Oct; 81(3):449-56. PubMed ID: 10507769
[TBL] [Abstract][Full Text] [Related]
46. Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
Bitran JD; Samuels B; Klein L; Hanauer S; Johnson L; Martinec J; Harris E; Kempler J; White W
Bone Marrow Transplant; 1996 Feb; 17(2):157-62. PubMed ID: 8640160
[TBL] [Abstract][Full Text] [Related]
47. Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: molecular basis for the anticancer effect of these molecules.
Margheri M; Pacini N; Tani A; Nosi D; Squecco R; Dama A; Masala E; Francini F; Zecchi-Orlandini S; Formigli L
Eur J Pharmacol; 2012 Apr; 681(1-3):34-43. PubMed ID: 22532966
[TBL] [Abstract][Full Text] [Related]
48. Complete objective response of neuroblastoma to biological treatment.
Di Bella G; Colori B
Neuro Endocrinol Lett; 2009; 30(4):437-49. PubMed ID: 20010503
[TBL] [Abstract][Full Text] [Related]
49. Melatonin and breast cancer: Evidences from preclinical and human studies.
Kubatka P; Zubor P; Busselberg D; Kwon TK; Adamek M; Petrovic D; Opatrilova R; Gazdikova K; Caprnda M; Rodrigo L; Danko J; Kruzliak P
Crit Rev Oncol Hematol; 2018 Feb; 122():133-143. PubMed ID: 29458781
[TBL] [Abstract][Full Text] [Related]
50. In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.
Conte PF; Gardin G; Pronzato P; Miglietta L; Rosso R; Amadori D; Gentilini P; Monzeglio C; Gallotti P; Demicheli R
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1103-8. PubMed ID: 1981014
[TBL] [Abstract][Full Text] [Related]
51. Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy.
Di Bella L; Di Bella G
Neuro Endocrinol Lett; 2015 Dec; 36(7):661-76. PubMed ID: 26859589
[TBL] [Abstract][Full Text] [Related]
52. Laudatio for centenary of the birth of Luigi Di Bella, MD, PhD.
Di Bella G; Di Bella A; Gualano L
Neuro Endocrinol Lett; 2012; 33(3):247-8. PubMed ID: 22635077
[TBL] [Abstract][Full Text] [Related]
53. Melatonin anticancer effects: review.
Di Bella G; Mascia F; Gualano L; Di Bella L
Int J Mol Sci; 2013 Jan; 14(2):2410-30. PubMed ID: 23348932
[TBL] [Abstract][Full Text] [Related]
54. Melatonin with adenosine solubilized in water and stabilized with glycine for oncological treatment - technical preparation, effectivity and clinical findings.
Di Bella G; Gualano L; Di Bella L
Neuro Endocrinol Lett; 2017 Dec; 38(7):465-474. PubMed ID: 29369596
[TBL] [Abstract][Full Text] [Related]
55. The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.
Smorodin E; Chuzmarov V; Veidebaum T
Curr Oncol; 2024 Apr; 31(4):1994-2023. PubMed ID: 38668052
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review.
Ramos E; Egea J; López-Muñoz F; Gil-Martín E; Romero A
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376065
[TBL] [Abstract][Full Text] [Related]
57. Recurrent Glioblastoma Multiforme (grade IV - WHO 2007): a case of complete objective response - concomitant administration of Somatostatin / Octreotide, Retinoids, Vit E, Vit D3, Vit C, Melatonin, D2 R agonists (Di Bella Method.
Di Bella G; Leci J; Ricchi A; Toscano R
Neuro Endocrinol Lett; 2015; 36(2):127-32. PubMed ID: 26071580
[TBL] [Abstract][Full Text] [Related]
58. Melatonin as a treatment for gastrointestinal cancer: a review.
Xin Z; Jiang S; Jiang P; Yan X; Fan C; Di S; Wu G; Yang Y; Reiter RJ; Ji G
J Pineal Res; 2015 May; 58(4):375-87. PubMed ID: 25752643
[TBL] [Abstract][Full Text] [Related]
59. Melatonin and vitamin D: complementary therapeutic strategies for breast cancer.
Vitti-Ruela BV; Dokkedal-Silva V; Hachul H; Tufik S; Andersen ML
Support Care Cancer; 2021 Jul; 29(7):3433-3434. PubMed ID: 33677716
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
